Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Alcidion Group Limited ( (AU:ALC) ).
Alcidion Group Limited has released its 2025 Corporate Governance Statement, detailing its adherence to the ASX Corporate Governance Council’s Principles and Recommendations. The company emphasizes the importance of strong corporate governance in ensuring future success, adding value to stakeholders, and enhancing investor confidence. The statement outlines the roles and responsibilities of the Board and management, the process for appointing directors, and the company’s commitment to diversity and inclusion. Alcidion also highlights its efforts towards gender equality and the implementation of a Reflect Reconciliation Action Plan and a Diversity and Inclusion Strategy for 2024-2026. These initiatives are aimed at fostering a diverse and inclusive workplace, which is seen as crucial for innovation and understanding customer needs.
The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited operates in the healthcare technology industry, providing innovative solutions to improve patient care and hospital operations. Their primary products and services include clinical decision support systems, patient flow management, and healthcare analytics, focusing on enhancing operational efficiency and patient outcomes in the healthcare sector.
Average Trading Volume: 1,304,886
Technical Sentiment Signal: Buy
Current Market Cap: A$134.3M
For detailed information about ALC stock, go to TipRanks’ Stock Analysis page.